Added a full section on medicines sold freely in India and Mexico that are controlled or unapproved in the United States, with a drug-by-drug table
Added the actual DEA rule for travelers, 21 CFR 1301.26, including the exact declaration wording and the 50-dosage-unit ceiling that applies to U.S. residents
Corrected the three-month supply passage: FDA describes it as discretionary enforcement, not an entitlement or a hard cap
Removed unsourced date claims and sourced the guidance to FDA’s personal importation page, current as of August 18, 2025
Added the U.S. Mission to Mexico warning that counterfeit pills sold at border and tourist-area pharmacies may contain fentanyl
Added FAQs and glossary entries covering the 50-dosage-unit rule and the definition of an unapproved drug
Key Takeaways
Travelers must keep medications in original containers and carry valid prescriptions for all drugs.
Foreign nationals are generally restricted to a 90-day supply of medication for personal use.
U.S. residents may import no more than 50 dosage units of controlled substances bought abroad, under 21 CFR 1301.26.
(UNITED STATES) Travelers entering the United States with prescription medications face tight rules from Customs and Border Protection and the Food and Drug Administration. The safest path is simple: keep drugs in original containers, carry a valid prescription, limit supplies to personal use, and declare everything at inspection.
Bringing Prescription Medications Into the U.S. for Personal Use
Those rules matter most for visitors, students, workers, and new immigrants who depend on daily treatment. They also matter for anyone carrying unapproved drugs, controlled substances, or mail-order refills. One mistake at the border can trigger seizure, delays, or a fine.
Border officers are checking labels, quantities, and intent
The core standard has not moved. FDA’s personal importation guidance, the page the agency points travelers to and which carries a content-current date of August 18, 2025, still turns on three things: the medicine must be lawfully obtained, packed for the traveler’s own use, and brought in a quantity that matches the trip. VisaVerge.com reports that CBP officers look closely at whether the amount seems reasonable for the length of stay.
For foreign nationals, the usual benchmark is a 90-day supply. FDA states plainly that it “will allow foreign nationals to bring or ship a 90-day supply of drug products,” and CBP repeats the same figure as a rule of thumb. That covers most vacation, work, and study trips. Travelers who stay longer may have additional medication sent to them, but each shipment needs paperwork that ties the medicine to the traveler and the stay.
U.S. citizens face stricter limits, and the reason is FDA approval rather than quantity. CBP’s own guidance says that “in most cases, it’s illegal for a U.S. citizen to obtain drugs from outside the U.S. and import for personal use,” because drugs sold abroad, “including foreign-made versions of drugs approved for use in the U.S.,” have not been evaluated by FDA. The agency “generally considers such drugs unapproved.” Domestic prescriptions are therefore the safe path.
The often-quoted three-month supply is worth stating precisely, because it is not a right and it is not a hard ceiling. FDA frames it as enforcement discretion: in listed situations, “FDA personnel may consider a more permissive decision.” One of those situations is a product for a serious condition for which effective treatment may not be available in the United States, and even then FDA lists several conditions together, including that the product is not being commercially promoted to U.S. residents, that it does not represent an unreasonable risk, that the consumer affirms in writing that it is for personal use, and that “the quantity is generally not more than a three month supply.” The traveler must also either name a U.S.-licensed doctor responsible for the treatment or show evidence that the treatment began in a foreign country. Meeting every one of those points does not oblige FDA to release the medicine. It only makes a favorable decision possible.
Original packaging matters because it helps officers verify the medication quickly. Labels should show the traveler’s name, the doctor’s name, and the drug details. A copy of the prescription and the doctor’s contact information makes inspection easier and reduces the risk of questions.
How to prepare the medication packet before travel
A well-organized medication packet keeps the border process calm and fast. The goal is to make every item easy to identify.
Travel proof, such as visa records, itinerary, or I-94 details
Declare the medicines verbally and on Form 6059B. Honesty matters. Failure to declare can lead to seizure, fines, or denied entry.
Travelers should also keep medicines close during flights. Checked bags get delayed, lost, or opened. Carry-on storage protects access if a flight is long or a connection is missed.
Controlled substances and cannabis face the strictest review
Extra caution applies to opioids, stimulants, sedatives, and other controlled substances. These drugs often need a prescription copy and a doctor’s note explaining why the medicine is medically necessary.
Medical marijuana and cannabis products are prohibited, even with a foreign prescription. Travelers should not assume a home-country prescription will help. It will not.
FDA also publishes the situations in which it would refuse a personal importation outright. Its list covers products already named on an FDA import alert, shipments that appear intended for commercial distribution rather than personal use, products that appear to present a serious risk to health, and articles that appear to represent health fraud. Weight-loss products, muscle-building products, and unbranded “cures” bought from foreign pharmacies or online sellers are the categories most likely to land in one of those buckets. FDA has said it is aware that patients look to unapproved versions of GLP-1 drugs such as semaglutide and tirzepatide for weight loss, and warns that these “do not undergo FDA’s review for safety, effectiveness and quality before they are marketed.” The agency has separately seized counterfeit Ozempic distributed outside the manufacturer’s authorized supply chain.
FDA does not make the call on these drugs. Its guidance says the “Drug Enforcement Agency (DEA) will generally make the decision on whether controlled substances are allowed to be imported for personal use,” with the two agencies coordinating where their jurisdictions overlap. CBP’s traveler guidance says the same thing: if the medicine is also a controlled substance, DEA requirements apply on top of FDA’s.
The DEA rule travelers actually use: 21 CFR 1301.26
There is a specific regulation for this, and most travelers have never heard of it. Under 21 CFR 1301.26, titled “Exemptions from import or export requirements for personal medical use,” an individual carrying a controlled substance in Schedule II, III, IV, or V that was lawfully obtained for personal medical use may enter or leave the United States with it, despite the general import bans in the Controlled Substances Act. There is no permit to apply for and no form to file in advance. The exemption is self-executing, but only if the traveler meets the conditions.
The regulation sets out two, and they are concrete. The controlled substance must be “in the original container in which it was dispensed to the individual.” And the traveler must make a declaration to a customs officer stating, first, that the substance is possessed for personal use, and second, the trade or chemical name and the schedule symbol as they appear on the container label. If the label does not carry that name, the traveler instead gives the name and address of the pharmacy or practitioner who dispensed it, plus the prescription number.
In practice that means the declaration is verbal and specific. Saying “I have some medication” is not the declaration the regulation describes. Naming the drug, saying it is a Schedule IV medicine prescribed for you, and handing over the labeled bottle is. Keep the pharmacy name, address, and prescription number written down as a fallback for any bottle with a worn or foreign-language label.
Important Notice
21 CFR 1301.26(c) adds a ceiling that catches people out: a United States resident may import “no more than 50 dosage units combined of all such controlled substances” obtained abroad. The regulation defines a U.S. resident by place of general abode, not by citizenship, so a visa holder living in the U.S. is covered. The 50-unit limit does not apply to controlled substances dispensed in the U.S. on a prescription from a DEA registrant.
That last point deserves emphasis for immigrants. A worker on an H-1B whose home is in the United States, who flies to India or Mexico and fills a prescription there, is a “United States resident” for this rule. The FDA’s 90-day allowance for foreign nationals does not override it, because the two rules answer different questions: FDA is asking whether the drug is approved, DEA is asking how much of a controlled substance may cross the border. Fifty dosage units of a twice-daily medicine is twenty-five days, not ninety.
Controlled substances lawfully filled at a U.S. pharmacy before a trip abroad are treated differently and are not subject to that 50-unit ceiling on the return leg. For anyone on a long-term controlled prescription, transferring care to a U.S. prescriber early is worth more than any border paperwork.
India and Mexico: pharmacy medicines that are controlled or unapproved in the U.S.
Two countries generate more medication trouble at U.S. ports of entry than almost any others, and for the same underlying reason. Retail pharmacy practice in India and Mexico is looser than in the United States. Drugs that a U.S. pharmacy will not hand over without a written prescription are routinely sold across the counter in both countries, often at a fraction of the U.S. price. Buying a medicine lawfully where you are standing does not change how the United States classifies it when you land.
Two separate federal tests apply, and a medicine can fail either one. The first is FDA approval. Per CBP, foreign-made versions of drugs approved for use in the U.S. still have not been evaluated by FDA, and FDA “generally considers such drugs unapproved.” The cheaper Indian-manufactured or Mexican-manufactured version of a pill already in your U.S. medicine cabinet is, in regulatory terms, an unapproved drug.
The second test is DEA scheduling. Several of the drugs most commonly bought without a prescription in both countries appear in Schedule IV of the federal controlled substances schedules at 21 CFR 1308.14. That pulls in the original-container rule, the spoken declaration, and the 50-dosage-unit ceiling described above.
Bought easily in India or Mexico, restricted in the United States
Medicine
U.S. federal status
Rule that applies at the border
Tramadol painkiller
Schedule IV
Original container plus spoken declaration under 21 CFR 1301.26. U.S. residents capped at 50 dosage units combined.
Alprazolam Xanax
Schedule IV
Same. Counts toward the same 50-unit combined ceiling.
Diazepam Valium
Schedule IV
Same. Counts toward the same 50-unit combined ceiling.
Clonazepam Klonopin, Rivotril
Schedule IV
Same. Counts toward the same 50-unit combined ceiling.
Zolpidem Ambien
Schedule IV
Same. A sleep aid sold far more freely abroad than in the U.S.
Carisoprodol Soma, muscle relaxant
Schedule IV
Same. A staple of Mexican border-pharmacy purchases.
Modafinil Provigil
Schedule IV
Same. Widely bought online and in Indian pharmacies.
Phentermine weight loss
Schedule IV
Same. Often sold abroad in combination diet products.
FDA withdrew approval of all dipyrone drugs for human use in 1977 after reports of agranulocytosis. Common in both countries; not lawful to import.
Nimesulide painkiller
Unapproved
Never marketed in the United States. An unapproved new drug, so importing it is not permitted.
Clenbuterol
Unapproved
No FDA approval for human use. The only U.S. approval is a veterinary product whose label reads “Not for use in humans.”
Foreign generic of a U.S. drug
Unapproved
Per CBP, foreign-made versions of U.S.-approved drugs are still treated as unapproved by FDA.
Schedule IV listings verified in 21 CFR 1308.14. Import status per FDA personal importation guidance (current 08/18/2025) and CBP prohibited and restricted items guidance. Not medical advice; check with the agencies and your prescriber before you travel.
For travelers coming from India, the recurring problems are painkillers and sedatives picked up at a neighborhood chemist, plus Ayurvedic and herbal preparations. Two everyday Indian painkillers illustrate the approval problem rather than the scheduling one. Nimesulide, sold widely across India, was never marketed in the United States, which makes it an unapproved new drug at the border. Metamizole, the drug in Analgin and Novalgin, is worse placed still: FDA withdrew approval of every dipyrone product for human use in 1977 after reports of agranulocytosis, a severe drop in white blood cells. Neither can be lawfully imported, however ordinary they are at home. On the herbal side, the issue is not scheduling but FDA’s refusal criteria: the agency says it would refuse a personal importation where the product sits on an FDA import alert, appears to present a serious risk to health, or appears to represent health fraud. A jar of unlabeled herbal tablets satisfies none of the identification that gets a medicine released quickly.
For travelers and residents crossing from Mexico, the classic pattern is the border-town pharmacy run: a day trip to buy a controlled medicine at a fraction of the U.S. price. The rules above make that a poor bet. The medicine is very likely unapproved in FDA terms, and if it is a Schedule IV drug, the 50-dosage-unit ceiling applies the moment the buyer is a U.S. resident. Quantity is also what CBP reads as intent. A supply that looks larger than one person’s reasonable course invites the question of whether it is meant for resale.
There is a safety problem layered on top of the legal one, and it is the more serious of the two. In a health alert on counterfeit pharmaceuticals, the U.S. Mission to Mexico warned that “counterfeit prescription pills are sold by criminals on both sides of the border,” that they are “sometimes represented as OxyContin, Percocet, Xanax and others, and may contain deadly doses of fentanyl,” and that they “can be purchased at small, non-chain pharmacies in Mexico along the border and in tourist areas.” The same alert tells travelers to “exercise caution when purchasing medication in Mexico,” noting that drugs requiring a prescription in the United States “are often readily available for purchase with little regulation” and that counterfeit medication “may prove to be ineffective, the wrong strength, or contain dangerous ingredients.”
Critical
A pill bought at a Mexican pharmacy and labeled as a familiar U.S. brand is not necessarily that drug. The U.S. Mission to Mexico has warned that counterfeits sold as OxyContin, Percocet or Xanax may contain fentanyl. This is a health warning, not only a customs one. Talk to a licensed clinician rather than substituting a foreign purchase for a prescription.
None of this is unique to the United States. Every country writes its own list, and the same medicine can be routine in one place and restricted in the next. Travelers heading elsewhere after a U.S. stay should check the destination separately; our guide to bringing prescription medications to the UK shows how differently a comparable regime can be built.
Over-the-counter medicine and supplements still need care
Over-the-counter products are more flexible, but they are not free from review. Travelers should carry only the amount needed for the trip and keep everything in original, unopened packaging.
Supplements and herbal remedies are treated carefully too. If a foreign product includes undeclared ingredients or a banned substance, officers can detain it. Travelers should also check whether a foreign brand matches an FDA-approved version in the United States.
Declare every tablet, powder, or capsule at inspection. Small violations can lead to fines. Larger problems can bring seizure and secondary screening.
Mailing medicines for longer stays
Mailing medication into the United States works for many foreign nationals who remain here longer than 90 days. It does not work the same way for U.S. citizens or permanent residents, especially when the shipment contains unapproved drugs.
Each package should include:
An English prescription or doctor’s letter
A passport or visa copy
Clear “personal use” labeling
Enough detail to show the medicine is for the traveler alone
Tracked couriers are safer than ordinary mail. CBP inspects inbound packages, and delays are common for temperature-sensitive products like insulin. A parcel with no English prescription, no patient name, and no proof of the sender is the one most likely to be held, because nothing in it distinguishes a personal supply from a commercial shipment. FDA lists exactly that appearance, a shipment that looks intended for commercial distribution, as a reason to refuse an import.
Addressing the package to a hotel, employer, or sponsor can help when the traveler has clear stay proof. That does not guarantee release, but it supports the case for personal use.
Medical devices travel under a similar logic
Devices such as CPAP machines, glucose monitors, and nebulizers are allowed when the traveler can show medical need. A doctor’s letter should explain the condition and the device’s function.
Batteries and accessories usually travel with the device. They still count as part of the medical kit, so travelers should pack them with the same care as medicines.
What the border process usually looks like
Most travelers are cleared quickly. Some are sent to secondary screening if officers want to inspect medicines more closely. That process is easier when documents are organized and answers are consistent.
The usual sequence is:
Present the medication kit at inspection
Show labels, prescriptions, and medical letters
Declare all medicines and supplements
Answer questions about quantity and purpose
Wait for release or a closer review
Officers focus on whether the supply matches the trip. A 30-day visitor may reasonably carry a little extra. A six-month student can usually show a 90-day supply and plan for refills later.
Why these rules matter for immigrants and visa applicants
The rules affect more than tourists. New arrivals on family, student, or work visas often need a medication bridge while they find a U.S. doctor and transfer prescriptions. A 90-day cushion helps, but overpacking creates suspicion.
Students should keep medication records with their I-20 paperwork. Workers should keep doctors’ letters with employment records. Families should bring enough proof to show that each medicine belongs to the traveler, not to resale or sharing.
People in asylum or refugee cases may have special health needs, but they still need foreign medical records at the border. A clean paper trail makes the difference between routine entry and a long delay.
For travelers who want the official rules, read them directly. FDA’s personal importation guidance covers approval and quantity, CBP’s prohibited and restricted items page covers what happens at inspection, and 21 CFR 1301.26 covers the controlled-substance declaration. Read all three before departure rather than after a bag is opened.
→ Common Questions
How much medication can I bring into the U.S. for personal use?+
Generally, you are allowed to bring up to a 90-day supply of medication. The quantity should be consistent with the length of stay indicated on your visa or travel itinerary.
Do I need to declare over-the-counter vitamins and supplements?+
Yes, you should declare all substances, including vitamins, herbal remedies, and over-the-counter medications, to avoid potential fines and secondary screening.
Can I bring medical marijuana if I have a legal prescription from my home country?+
No. Medical marijuana and cannabis products are prohibited under U.S. federal law, and foreign prescriptions are not recognized at the border.
What happens if I don’t have the original packaging for my medicine?+
If you lack original packaging, you risk medication seizure, delays, or fines. CBP officers use the original labels to quickly verify the drug, patient, and prescribing doctor.
Can I have medication mailed to me while I am in the United States?+
Yes, foreign nationals staying longer than 90 days can have medications mailed, provided the package includes a copy of the prescription, a doctor’s letter, and proof of personal use.
Can I bring medicine I bought at a pharmacy in India or Mexico into the U.S.?+
Often no, or not in the amount you bought. CBP says foreign-made versions of drugs approved in the U.S. have still not been evaluated by FDA, which generally considers them unapproved. If the drug is also a controlled substance such as tramadol or alprazolam, 21 CFR 1301.26 applies and a U.S. resident is capped at 50 dosage units combined.
How many pills of a controlled substance can I bring into the United States?+
Under 21 CFR 1301.26(c), a United States resident may import no more than 50 dosage units combined of all controlled substances obtained abroad. Residence is defined by where you actually live, not by citizenship. The cap does not apply to controlled substances dispensed in the U.S. on a prescription from a DEA registrant.
Is the three-month supply rule a guarantee?+
No. FDA frames it as enforcement discretion, not an entitlement. Its guidance says FDA personnel may consider a more permissive decision in listed situations, and the three-month figure appears only inside the serious-condition branch alongside other conditions, including a written personal-use affirmation and either a U.S. doctor’s name or proof the treatment began abroad.
What exactly do I say to the CBP officer about a controlled medication?+
21 CFR 1301.26 requires a declaration that the substance is for your personal use, plus the trade or chemical name and the schedule symbol from the container label. If the label does not show that name, give the name and address of the pharmacy or practitioner who dispensed it and the prescription number. The medicine must be in its original container.
Is it safe to buy prescription drugs at a pharmacy in Mexico?+
The U.S. Mission to Mexico has warned that counterfeit pills sold as OxyContin, Percocet or Xanax may contain deadly doses of fentanyl, and that they can be bought at small, non-chain pharmacies along the border and in tourist areas. It advises exercising caution and buying only in consultation with a medical professional.
?
People also ask
Answers from VisaVerge guides
What are the key considerations when bringing prescription medications to the UK?
Key considerations include having a valid prescription, knowing medication limits, particularly for controlled substances, and declaring medications upon arrival.
How do drug offenses affect travel to the United States?
Drug offenses can have a significant impact on your ability to travel to the U.S., with anyone convicted of or who admits to having violated any law related to controlled substances, except for a single offense of simple possession of 30 grams or less of marijuana, potentially being inadmissible.
Kenji Tanaka is the Travel & Border Correspondent at VisaVerge.com, focusing on entry requirements, visa-free travel, ESTA, the Schengen area, and passport rules worldwide. He keeps globe-trotters, tourists, and digital nomads ahead of changing border policies and documentation requirements. Kenji's practical, up-to-date guides take the guesswork out of crossing international borders smoothly.
Learn U.S. customs rules for 2026 regarding 90-day medicine supplies, declaring controlled substances, and bringing personal gifts without resale intent.
